BR9815745A - Combinações de inibidor de metaloproteinase de matriz estatina - Google Patents

Combinações de inibidor de metaloproteinase de matriz estatina

Info

Publication number
BR9815745A
BR9815745A BR9815745-0A BR9815745A BR9815745A BR 9815745 A BR9815745 A BR 9815745A BR 9815745 A BR9815745 A BR 9815745A BR 9815745 A BR9815745 A BR 9815745A
Authority
BR
Brazil
Prior art keywords
statin
combinations
matrix metalloproteinase
metalloproteinase inhibitor
inhibitor
Prior art date
Application number
BR9815745-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Roger Schofield Newton
Bruce David Roth
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR9815745A publication Critical patent/BR9815745A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9815745-0A 1998-03-17 1998-11-20 Combinações de inibidor de metaloproteinase de matriz estatina BR9815745A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7826598P 1998-03-17 1998-03-17
PCT/US1998/024681 WO1999047138A1 (en) 1998-03-17 1998-11-20 Statin-matrix metalloproteinase inhibitor combinations

Publications (1)

Publication Number Publication Date
BR9815745A true BR9815745A (pt) 2000-11-14

Family

ID=22142950

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815745-0A BR9815745A (pt) 1998-03-17 1998-11-20 Combinações de inibidor de metaloproteinase de matriz estatina

Country Status (18)

Country Link
EP (1) EP1063991A1 (cg-RX-API-DMAC7.html)
JP (1) JP2002506818A (cg-RX-API-DMAC7.html)
KR (1) KR20010041916A (cg-RX-API-DMAC7.html)
AR (1) AR018113A1 (cg-RX-API-DMAC7.html)
AU (1) AU1591699A (cg-RX-API-DMAC7.html)
BR (1) BR9815745A (cg-RX-API-DMAC7.html)
CA (1) CA2309588A1 (cg-RX-API-DMAC7.html)
CO (1) CO5070670A1 (cg-RX-API-DMAC7.html)
GT (1) GT199900039A (cg-RX-API-DMAC7.html)
HN (1) HN1999000029A (cg-RX-API-DMAC7.html)
MY (1) MY140504A (cg-RX-API-DMAC7.html)
NZ (1) NZ505994A (cg-RX-API-DMAC7.html)
PA (1) PA8469001A1 (cg-RX-API-DMAC7.html)
PE (1) PE20000348A1 (cg-RX-API-DMAC7.html)
SV (1) SV1999000026A (cg-RX-API-DMAC7.html)
UY (1) UY25436A1 (cg-RX-API-DMAC7.html)
WO (1) WO1999047138A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA992106B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US7816347B2 (en) 2004-12-15 2010-10-19 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
BRPI0618379A2 (pt) * 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
WO2010005389A1 (en) * 2008-07-11 2010-01-14 Forskarpatent I Syd Ab Oxidized ldl specific antibody-fusion and conjugated proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ127198A3 (cs) * 1995-11-02 1998-12-16 Warner-Lambert Company Způsob regulace koncentrace lipidů a farmaceutická kompozice pro tento způsob
CZ294063B6 (cs) * 1996-05-17 2004-09-15 Warner-Lambert Company Bifenylsulfonamid, jeho použití a farmaceutický prostředek s jeho obsahem
MXPA99001974A (es) * 1996-12-09 2002-03-27 Warner Lambert Co Metodo para tratar y prevenir fallas cardiacas y dilatacion ventricular.
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.

Also Published As

Publication number Publication date
KR20010041916A (ko) 2001-05-25
WO1999047138A1 (en) 1999-09-23
UY25436A1 (es) 2001-10-25
JP2002506818A (ja) 2002-03-05
PE20000348A1 (es) 2000-05-22
AR018113A1 (es) 2001-10-31
AU1591699A (en) 1999-10-11
ZA992106B (en) 1999-09-30
NZ505994A (en) 2003-10-31
CO5070670A1 (es) 2001-08-28
GT199900039A (es) 2000-09-06
CA2309588A1 (en) 1999-09-23
HN1999000029A (es) 1999-09-29
MY140504A (en) 2009-12-31
EP1063991A1 (en) 2001-01-03
SV1999000026A (es) 2000-01-18
PA8469001A1 (es) 2002-09-17

Similar Documents

Publication Publication Date Title
BR0113669A (pt) Inibidores da desacetilase
BR9809793A (pt) Monoésteres de probucol para o tratamento de doença inflamatória e cardiovascular
BR9805544A (pt) Uso de um composto.
AR032086A1 (es) Combinaciones de farmacos
BR0212014A (pt) Uso de derivados do ácido hidroxâmico inibidores da enzima histone deacetilase
PA8506101A1 (es) Uso de un compuesto acat para fabricar una composicion farmaceutica
FI940012A0 (fi) Aryylisulfonamidosubstituoidut hydroksaamihapot
BR9812753A (pt) Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica
BR0317715A (pt) Composições e processos de uso de collajolie
ATE266000T1 (de) Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung
BR9711194A (pt) Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer.
NO973035D0 (no) Hydroksaminsyre-holdige inhibitorer for matriks-metallproteaser
EE200000093A (et) Agrekanaasi ja maatriksmetalloproteinaaside uudsed inhibiitorid artriidi käitlemiseks
BR9812371A (pt) Tratamento de distúrbio de conduta
ES2196190T3 (es) Inhibidores de metaloproteinasas matriciales, con hidroxamato bifenlico.
ATE266634T1 (de) Cyclobutyl-aryloxysulfonylamin- hydroxamsäurederivate
BR9812357A (pt) Tratamento de distúbio oposicional desafiador
FR2834890B1 (fr) Composition pharmaceutique orodispersible d'agomelatine
BR9714142A (pt) Uso de inibidores de metaloproteìnases matriciais para tratamento de distúrbios neurológicos e promoção de cicatrização de feridas
PT1169337E (pt) Nitratos esteroides para o tratamento de lesoes oxidativas e disfuncoes endoteliais
EA200401183A1 (ru) Применение ингибиторов il-18 в качестве диагностического маркера
BR9804027A (pt) Novos beta-ceto ésteres
BR0112212A (pt) Uma combinação de inibidores de fbpase e agentes antidiabéticos úteis para o tratamento de diabetes
ATE448774T1 (de) Kosmetische zusammensetzung enthaltend ein siegesbeckia extrakt und ein lipopeptid
ES2141330T3 (es) Monohidrato de (e)-2'-desoxi-2'-(fluorometileno)citidina.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 45/06, A61P 9/10

Ipc: A61K 31/40 (2008.04)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.